Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death
Apoptosis is a key mechanism for metazoans to eliminate unwanted cells. Resistance to apoptosis is a hallmark of many cancer cells and a major roadblock to traditional chemotherapy. Recent evidence indicates that inhibition of caspase-dependent apoptosis sensitizes many cancer cells to a form of non...
Main Authors: | Moriwaki, K, Bertin, J, Gough, P J, Orlowski, G M, Chan, F KM |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669795/ |
Similar Items
-
Necroptosis: Fifty shades of RIPKs
by: Ichim, Gabriel, et al.
Published: (2014) -
Absence of RIPK3 predicts necroptosis resistance in malignant melanoma
by: Geserick, P, et al.
Published: (2015) -
Necroptosis induced by RIPK3 requires MLKL but not Drp1
by: Moujalled, D M, et al.
Published: (2014) -
Neoalbaconol induces cell death through necroptosis by regulating RIPK-dependent autocrine TNFα and ROS production
by: Yu, Xinfang, et al.
Published: (2014) -
Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis
by: Remijsen, Q, et al.
Published: (2014)